Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00495079
Status:
COMPLETED
Last Update Posted:
2021-03-05
First Post:
2007-06-28
Brief Title:
Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
Sponsor:
Spectrum Pharmaceuticals Inc
Organization:
Spectrum Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Lymphoblastic Leukemia ALL |
Keywords:
| Name | View |
|---|---|
| acute | View |
| lymphocytic | View |
| leukaemia | View |
| lukemia | View |
| ALL | View |
| Marqibo | View |
| Hana Biosciences | View |
| vincristine | View |
| liposomal | View |
| liposome | View |
| optisome | View |
| hematology | View |
| malignancy | View |
| hematological | View |
| relapsed | View |
| anti-leukemia | View |
| adult | View |
| lymphoblastic | View |
| leukemia | View |
| leukimia | View |
| chemotherapy | View |